Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes

Aina Areny Balagueró, Marta Camprubí Rimblas, Raquel Guillamat Prats, Lluis Blanch, Anna Roig, Daniel Closa, Antonio Artigas
European Respiratory Journal 2021 58: PA3617; DOI: 10.1183/13993003.congress-2021.PA3617
Aina Areny Balagueró
1Fundació Parc Taulí (FPT), Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aareny@tauli.cat
Marta Camprubí Rimblas
1Fundació Parc Taulí (FPT), Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Guillamat Prats
1Fundació Parc Taulí (FPT), Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lluis Blanch
1Fundació Parc Taulí (FPT), Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Roig
2Institut de Ciència de Materials de Barcelona (ICMAB), Bellaterra, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Closa
3Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Artigas
1Fundació Parc Taulí (FPT), Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

In this study we aimed to determine the effect of the exosomes derived from Mesenchymal stromal cells (MSC) on cell proliferation, and to study how pre-conditioning the MSCs to a septic environment, changes their exosomes’ content and consequently, their regenerative capacity.

MSC were isolated from male rats’ femora and tibiae and cultured in non pre-stimulated and pre-stimulated (with LPS) conditions. The secreted exosomes were obtained via standard ultracentrifugation protocol. Cell proliferation experiments were conducted by treating an epithelial cell line with exosomes from non pre-stimulated MSC (Control exosomes) and pre-stimulated MSC (LPS exosomes) through an in vitro scratch assay. Exosomal protein profile was analyzed by a liquid chromatography-mass spectrometry analysis.

The treatment of epithelial cells with LPS exosomes increases a 10% its capacity to proliferate and to heal the wound in comparison with the cells treated with Control exosomes (Fig.1a). The analysis of the protein content of both types of exosomes confirmed that pre-conditioning MSCs to a septic environment modifies the protein cargo of its exosomes (Fig. 1b), resulting in the appearance proteins related to cell cycle regulation and cell proliferation.

In conclusion, pre-stimulating MSC with LPS enhances their paracrine activity and improves the reparative capacity of their secreted exosomes.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • Sepsis
  • Treatments
  • ARDS (Acute Respiratory Distress Syndrome)

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3617.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes
Aina Areny Balagueró, Marta Camprubí Rimblas, Raquel Guillamat Prats, Lluis Blanch, Anna Roig, Daniel Closa, Antonio Artigas
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3617; DOI: 10.1183/13993003.congress-2021.PA3617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes
Aina Areny Balagueró, Marta Camprubí Rimblas, Raquel Guillamat Prats, Lluis Blanch, Anna Roig, Daniel Closa, Antonio Artigas
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3617; DOI: 10.1183/13993003.congress-2021.PA3617
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection
  • LSC - 2021 - Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
  • LSC - 2021 - Club cell functions as a Wnt-responsive progenitor for tissue repair in COPD
Show more Mechanisms of lung injury and repair

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society